An Evaluation of the Influenza-Associated Pediatric Mortality Surveillance System in Detecting Influenza Associated Encephalopathy during the 2024-2025 Influenza Season

What to know

  • Presentation Day/Time: Wednesday, April 22, 1:05 PM
  • Presenter: Patrick Maloney, PhD, MPH, National Center for Immunization and Respiratory Diseases, Influenza Division
Patrick Maloney, PhD, MPH

The Issue

  • Pediatric influenza-associated encephalopathy (IAE) can cause severe illness and death. IAE surveillance is not routine in the United States, but the Influenza-Associated Pediatric Mortality Surveillance System passively captures complications which can serve as proxy for IAE. We wanted to assess its performance in detecting IAE deaths.

What We Did

  • During the 2024–25 flu season, in response to anecdotal reports of IAE, CDC implemented national pediatric IAE surveillance. Flu-associated pediatric deaths with encephalopathy or encephalitis identified in the passive system were compared with IAE deaths detected and verified by this active system.

What We Found

  • The passive system proved to have moderate sensitivity, specificity, and positive predictive value (PPV) for detecting IAE deaths.

What This Means

  • Training reporters about IAE and collecting additional clinical information about pediatric deaths might improve the sensitivity, specificity, and PPV of the Influenza-Associated Pediatric Mortality Surveillance System.